[LAZEAR H M, SCHOGGINS J W, DIAMOND M S. Shared and Distinct Functions of Type I and Type III Interferons [J]. Immunity, 2019, 50(4): 907-23.
[2] MESEV E V, LEDESMA R A, PLOSS A. Decoding type I and III interferon signalling during viral infection [J]. Nat Microbiol, 2019, 4(6): 914-24.
[3] SCHOGGINS J W. Recent advances in antiviral interferon- stimulated gene biology [J]. F1000Res, 2018, 7: 309.
[4] WALSH M J, STUMP C T, KURESHI R, et al. IFNgamma is a central node of cancer immune equilibrium [J]. Cell Rep, 2023, 42(3): 112219.
[5] SCOTT H M, SMITH M H, COLEMAN A K, et al. Serine/arginine- rich splicing factor 7 promotes the type I interferon response by activating Irf7 transcription [J]. Cell Rep, 2024, 43(3): 113816.
[6] APARICI-HERRAIZ I, SANCHEZ-SANCHEZ G, BATLLE C, et al. IRF1 Is Required for MDA5 (IFIH1) Induction by IFN-alpha, LPS, and poly(I:C) in Murine Macrophages [J]. J Innate Immun, 2023, 15(1): 297-316.
[7] SCHOGGINS J W. Interferon-Stimulated Genes: What Do They All Do? [J]. Annu Rev Virol, 2019, 6(1): 567-84.
[8] LIAN H, ZANG R, WEI J, et al. The Zinc-Finger Protein ZCCHC3 Binds RNA and Facilitates Viral RNA Sensing and Activation of the RIG-I-like Receptors [J]. Immunity, 2018, 49(3): 438-48 e5.
[9] IWASAKI A. A virological view of innate immune recognition [J]. Annu Rev Microbiol, 2012, 66: 177-96.
[10] TSENG Y Y, GOWRIPALAN A, CROFT S N, et al. Viperin has species-specific roles in response to herpes simplex virus infection [J]. J Gen Virol, 2021, 102(8).
[11] SCHNEIDER W M, CHEVILLOTTE M D, RICE C M. Interferon- stimulated genes: a complex web of host defenses [J]. Annu Rev Immunol, 2014, 32: 513-45.
[12] FEKETE T, BENCZE D, SZABO A, et al. Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory61参考文献 Responses in Human Dendritic Cells [J]. Front Immunol,2018, 9: 2314.
[13] GABRIELE L, FRAGALE A, ROMAGNOLI G, et al. Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19 [J]. Cytokine Growth Factor Rev, 2021, 58: 66-74.
[14] GILANIPOUR A, TEIMOORI A, ARABZADEH S A, et al. Toll-like receptor 7 and RIG-I-like receptors expression in peripheral blood mononuclear cells of naive patients with hepatitis C [J]. BMC Res Notes, 2023, 16(1): 344.
[15] GEBHARDT A, LAUDENBACH B T, PICHLMAIR A. Discrimination of Self and Non-Self Ribonucleic Acids [J]. J Interferon Cytokine Res, 2017, 37(5): 184-97.
[16] WACK A, TERCZYNSKA-DYLA E, HARTMANN R. Guarding the frontiers: the biology of type III interferons [J]. Nat Immunol, 2015, 16(8): 802-9.
[17] CHEN M, WANG S. Preclinical development and clinical studies of targeted JAK/STAT combined Anti-PD-1/PD-L1 therapy [J]. Int Immunopharmacol, 2024, 130: 111717.
[18] HUSAIN M. Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs [J]. Pathogens, 2024, 13(2).
[19] CROSSE K M, MONSON E A, BEARD M R, et al. Interferon- Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling [J]. J Innate Immun, 2018, 10(2): 85-93.
[20] CHATELAINE H A S, CHEN Y, BRAISTED J, et al. Nucleotide, Phospholipid, and Kynurenine Metabolites Are Robustly Associated with COVID-19 Severity and Time of Plasma Sample Collection in a Prospective Cohort Study [J]. Int J Mol Sci, 2023, 25(1).
[21] BOSCHI D, PIPPIONE A C, SAINAS S, et al. Dihydroorotate dehydrogenase inhibitors in anti-infective drug research [J]. Eur J Med Chem, 2019, 183: 111681.
[22] MUNGER J, BAJAD S U, COLLER H A, et al. Dynamics of the cellular metabolome during human cytomegalovirus infection [J]. PLoS Pathog, 2006, 2(12): e132.
[23] CONSIGLI R A, GINSBERG H S. Control of aspartate transcarbamylase activity in type 5 adenovirus-infected HeLa cells [J]. J Bacteriol, 1964, 87(5): 1027-33.
[24] REIS R A G, CALIL F A, FELICIANO P R, et al. The dihydroorotate dehydrogenases: Past and present [J]. Arch Biochem Biophys, 2017, 632: 175-91.62参考文献
[25] ALAMRI R D, ELMELIGY M A, ALBALAWI G A, et al. Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review [J]. Int Immunopharmacol, 2021, 93: 107398.
[26] ZHENG Y, LI S, SONG K, et al. A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses [J]. Viruses, 2022, 14(5).
[27] LUCAS-HOURANI M, DAUZONNE D, JORDA P, et al. Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity [J]. PLoS Pathog, 2013, 9(10): e1003678.
[28] JIN L, LI Y, PU F, et al. Inhibiting pyrimidine biosynthesis impairs Peste des Petits Ruminants Virus replication through depletion of nucleoside pools and activation of cellular immunity [J]. Vet Microbiol, 2021, 260: 109186.
[29] WANG J, SUN J, HU J, et al. A77 1726, the active metabolite of the anti-rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases [J]. FASEB J, 2020, 34(8): 10132-45.
[30] CHEUNG N N, LAI K K, DAI J, et al. Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response [J]. J Gen Virol, 2017, 98(5): 946-54.
[31] CHEN S F, RUBEN R L, DEXTER D L. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl- 4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis [J]. Cancer Res, 1986, 46(10): 5014-9.
[32] CHEN S F, PAPP L M, ARDECKY R J, et al. Structure-activity relationship of quinoline carboxylic acids. A new class of inhibitors of dihydroorotate dehydrogenase [J]. Biochem Pharmacol, 1990, 40(4): 709-14.
[33] EIRAS-HREHA G, CRAMER D V, CAJULIS E, et al. Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium [J]. Transplant Proc, 1993, 25(1 Pt 1): 708-9.63参考文献
[34] JAFFEE B D, JONES E A, LOVELESS S E, et al. The unique immunosuppressive activity of brequinar sodium [J]. Transplant Proc, 1993, 25(3 Suppl 2): 19-22.
[35] KANG I H, EMPTAGE R P, KIM S I, et al. A Novel mechanism of herbicide action through disruption of pyrimidine biosynthesis [J]. Proc Natl Acad Sci U S A, 2023, 120(48): e2313197120.
[36] KAWATANI M, AONO H, HIRANUMA S, et al. Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling [J]. Oncol Res, 2023, 31(6): 833-44.
[37] WU S, ZHOU F, ZHANG Z, et al. Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins [J]. FEBS J, 2011, 278(6): 941-54.
[38] LIU X, HAJNOCZKY G. Altered fusion dynamics underlie unique morphological changes in mitochondria during hypoxia- reoxygenation stress [J]. Cell Death Differ, 2011, 18(10): 1561-72.
[39] SRINIVASAN S, GUHA M, DONG D W, et al. Disruption of cytochrome c oxidase function induces the Warburg effect and metabolic reprogramming [J]. Oncogene, 2016, 35(12): 1585-95.
[40] PICARD M, SHIRIHAI O S, GENTIL B J, et al. Mitochondrial morphology transitions and functions: implications for retrograde signaling? [J]. Am J Physiol Regul Integr Comp Physiol, 2013, 304(6): R393-406.
[41] WOJTYNIAK P, BORATYNSKA-JASINSKA A, SERWACH K, et al. Mitofusin 2 Integrates Mitochondrial Network Remodelling, Mitophagy and Renewal of Respiratory Chain Proteins in Neurons after Oxygen and Glucose Deprivation [J]. Mol Neurobiol, 2022, 59(10): 6502-18.
[42] SONG Y, REN S, CHEN X, et al. Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics [J]. Cancer Lett, 2024, 590: 216847.
[43] OLICHON A, BARICAULT L, GAS N, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis [J]. J Biol Chem, 2003, 278(10): 7743-6.64
[52] HAN Y, KIM B, CHO U, cisplatin resistance ovarian cancer cellset al. Mitochondrial fission causes under hypoxic conditions via ROS in [J]. Oncogene, 2019, 38(45): 7089-105.参考文献
[44] TIAN T, PANG H, LI X, et al. The role of DRP1 mediated mitophagy in HT22 cells apoptosis induced by silica nanoparticles [J]. Ecotoxicol Environ Saf, 2024, 272: 116050.
[45] CHANG C R, BLACKSTONE C. Cyclic AMP-dependent protein kinase phosphorylation of DRP1 regulates its GTPase activity and mitochondrial morphology [J]. J Biol Chem, 2007, 282(30): 21583-7.
[46] JIN J Y, WEI X X, ZHI X L, et al. DRP1-dependent mitochondrial fission in cardiovascular disease [J]. Acta Pharmacol Sin, 2021, 42(5): 655-64.
[47] MENG H, YAN W Y, LEI Y H, et al. SIRT3 Regulation of Mitochondrial Quality Control in Neurodegenerative Diseases [J]. Front Aging Neurosci, 2019, 11: 313.
[48] TROTTA A P, CHIPUK J E. Mitochondrial dynamics as regulators of cancer biology [J]. Cell Mol Life Sci, 2017, 74(11): 1999-2017.
[49] GAO T, ZHANG X, ZHAO J, et al. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1alpha pathway and DRP1-mediated mitochondrial fission in ovarian cancer [J]. Cancer Lett, 2020, 469: 89-101.
[50] ZHAO J, ZHANG J, YU M, et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells [J]. Oncogene, 2013, 32(40): 4814-24.
[51] KAWADA I, HASINA R, LENNON F E, et al. Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer [J]. Cancer Biol Ther, 2013, 14(7): 679-91.
[53] SEO J H, AGARWAL E, CHAE Y C, et al. Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer [J]. EBioMedicine, 2019, 48: 353-63.
[54] KUMAR S, ASHRAF R, C K A. Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer [J]. Cell Biol Toxicol, 2022, 38(3): 377-406.
[55] CAGIN U, ENRIQUEZ J A. The complex crosstalk between mitochondria and the nucleus: What goes in between? [J]. Int J Biochem Cell Biol, 2015, 63: 10-5.65参考文献
[56] KRAUS F, ROY K, PUCADYIL T J, et al. Function and regulation of the divisome for mitochondrial fission [J]. Nature, 2021, 590(7844): 57-66.
[57] KLEELE T, REY T, WINTER J, et al. Distinct fission signatures predict mitochondrial degradation or biogenesis [J]. Nature, 2021, 593(7859): 435-9.
[58] MONZEL A S, ENRIQUEZ J A, PICARD M. Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction [J]. Nat Metab, 2023, 5(4): 546-62.
[59] GILKERSON R W, SELKER J M, CAPALDI R A. The cristal membrane of mitochondria is the principal site of oxidative phosphorylation [J]. FEBS Lett, 2003, 546(2-3): 355-8.
[60] YU R, LIU T, JIN S B, et al. MIEF1/2 function as adaptors to recruit DRP1 to mitochondria and regulate the association of DRP1 with Mff [J]. Sci Rep, 2017, 7(1): 880.
[61] GIACOMELLO M, PYAKUREL A, GLYTSOU C, et al. The cell biology of mitochondrial membrane dynamics [J]. Nat Rev Mol Cell Biol, 2020, 21(4): 204-24.
[62] ZHU P P, PATTERSON A, STADLER J, et al. Intra- and intermolecular domain interactions of the C-terminal GTPase effector domain of the multimeric dynamin-like GTPase DRP1 [J]. J Biol Chem, 2004, 279(34): 35967-74.
[63] ISHIHARA N, NOMURA M, JOFUKU A, et al. Mitochondrial fission factor DRP1 is essential for embryonic development and synapse formation in mice [J]. Nat Cell Biol, 2009, 11(8): 958-66.
[64] YU Y, XU L, QI L, et al. ABT737 induces mitochondrial pathway apoptosis and mitophagy by regulating DRP1- dependent mitochondrial fission in human ovarian cancer cells [J]. Biomed Pharmacother, 2017, 96: 22-9.
[65] SERASINGHE M N, CHIPUK J E. Mitochondrial Fission in Human Diseases [J]. Handb Exp Pharmacol, 2017, 240: 159-88.
[66] LIU Y, SHI Y. Mitochondria as a target in cancer treatment[J]. MedComm (2020), 2020, 1(2): 129-39.
[67] FERREIRA-DA-SILVA A, VALACCA C, RIOS E, et al.Mitochondrial dynamics protein DRP1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration [J]. PLoS One, 2015, 10(3): e0122308.
[68] DONG H, SHEN J. MAVS Ubiquitylation: Function, Mechanism, and Beyond [J]. Front Biosci (Landmark Ed), 2024, 29(2): 72.66参考文献
[69] SMITH L H, JR., BAKER F A. Pyrimidine metabolism in man. I. The biosynthesis of orotic acid [J]. J Clin Invest, 1959, 38(5): 798-809.
[70] ONOGUCHI K, ONOMOTO K, TAKAMATSU S, et al. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1 [J]. PLoS Pathog, 2010, 6(7): e1001012.
[71] ZHANG Q, JIANG L, WANG W, et al. Potentiating the radiation-induced type I interferon anti-tumoral immune response by ATM inhibition in pancreatic cancer [J]. JCI Insight, 2024.
[72] KIM S J, SYED G H, KHAN M, et al. Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence [J]. Proc Natl Acad Sci U S A, 2014, 111(17): 6413-8.
[73] ZANFARDINO P, AMATI A, DOCCINI S, et al. OPA1 mutation affects autophagy and triggers senescence in autosomal dominant optic atrophy plus fibroblasts [J]. Hum Mol Genet, 2024.
[74] LI X, ZHU Y, RUIZ-LOZANO P, et al. Mitochondrial-to-nuclear communications through multiple routes regulate cardiomyocyte proliferation [J]. Cell Regen, 2024, 13(1): 2.
[75] TANG J, ZHU J, XIE H, et al. Mitochondria-Specific Molecular Crosstalk between Ferroptosis and Apoptosis Revealed by In Situ Raman Spectroscopy [J]. Nano Lett, 2024, 24(7): 2384-91.
[76] RUN C, YANG Q, LIU Z, et al. Molecular Basis of MgATP Selectivity of the Mitochondrial SCaMC Carrier [J]. Structure, 2015, 23(8): 1394-403.
[77] CARTY M, GUY C, BOWIE A G. Detection of Viral Infections by Innate Immunity [J]. Biochem Pharmacol, 2021, 183: 114316.
[78] CHEN M, YU S, VAN DER SLUIS T, et al. cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer [J]. NPJ Breast Cancer, 2024, 10(1): 1.
[79] BARNES T, PARRY P, HART I, et al. Regional mapping of the gene encoding dihydroorotate dehydrogenase, an enzyme involved in UMP synthesis, electron transport, and superoxide generation, to human chromosome region 16q22 [J]. Somat Cell Mol Genet, 1993, 19(4): 405-11.67Immunity Meet at2021, 9: 720490.
[85] JIANG Z, ZHOU X, with sequencing:the Mitochondria [J]. Front Cell Dev Biol,LI R, et al. Whole transcriptome analysis参考文献
[80] PLATANITIS E, DECKER T. Regulatory Networks Involving STATs, IRFs, and NFkappaB in Inflammation [J]. Front Immunol, 2018, 9: 2542.
[81] ORZALLI M H, SMITH A, JURADO K A, et al. An Antiviral Branch of the IL-1 Signaling Pathway Restricts Immune- Evasive Virus Replication [J]. Mol Cell, 2018, 71(5): 825- 40 e6.
[82] YASUKAWA K, OSHIUMI H, TAKEDA M, et al. Mitofusin 2 inhibits mitochondrial antiviral signaling [J]. Sci Signal, 2009, 2(84): ra47.
[83] CHEN J, XIA L, WANG W, et al. Identification of a mitochondrial-targeting secretory protein from Nocardia seriolae which induces apoptosis in fathead minnow cells [J]. J Fish Dis, 2019, 42(11): 1493-507.
[84] BAHAT A, MACVICAR T, LANGER T. Metabolism and Innatemethods, challenges and potential solutions [J]. Cell Mol Life Sci, 2015, 72(18): 3425-39.
[86] WANG Y, LIU B, ZHAO G, et al. Spatial transcriptomics: Technologies, applications and experimental considerations [J]. Genomics, 2023, 115(5): 110671.
[87] DE ROP F V, ISMAIL J N, BRAVO GONZALEZ-BLAS C, et al. Hydrop enables droplet-based single-cell ATAC-seq and single-cell RNA-seq using dissolvable hydrogel beads [J]. Elife, 2022, 11.
[88] WITHANAGE M H H, LIANG H, ZENG E. RNA-Seq Experiment and Data Analysis [J]. Methods Mol Biol, 2022, 2418: 405-24.
[89] LOVE M I, HUBER W, ANDERS S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 [J]. Genome Biol, 2014, 15(12): 550.
[90] NYENHUIS S B, WU X, STRUB M P, et al. OPA1 helical structures give perspective to mitochondrial dysfunction [J]. Nature, 2023, 620(7976): 1109-16.
修改评论